Heidelberg University
Clinical trials sponsored by Heidelberg University, explained in plain language.
-
New combo therapy aims to shrink lymphoma with less radiation
Disease control CompletedThis study tested a new approach for people with early-stage follicular lymphoma, a slow-growing blood cancer. Instead of standard full-dose radiation, participants received low-dose radiation combined with the drug Obinutuzumab (Gazyvaro). The goal was to see if this combination…
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Snap to clear: photos may help surgeons remove all cancer in one go
Knowledge-focused CompletedThis study tested whether sharing photos between surgeons and pathologists during head and neck cancer surgery could improve the removal of all cancerous tissue. Normally, they only talk by phone. Here, 155 patients had photos taken of their tumors and surgical margins, which wer…
Phase: NA • Sponsor: Heidelberg University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC